Vaxine Pty Ltd

This study tested a new COVID-19 vaccine called SpikoGen in 39 adults who had never received a COVID-19 vaccine. Participants received two doses one month apart, followed by a third booster dose either one or three months later. The goal was to see how well the vaccine triggered …

This study tested the SpikoGen vaccine as a booster shot in 81 adults who had already received a full course of any COVID-19 vaccine. The goal was to see if a third or fourth dose of SpikoGen could raise antibody levels and provide protection. Researchers measured immune response…